−830 KRW
−7.52 B KRW
13.11 B KRW
6.77 M
About S.BIOMEDICS CO., LTD.
Sector
Headquarters
Seoul
Website
Founded
2003
ISIN
KR7304360001
FIGI
BBG01F7NP2D1
S.Biomedics Co. Ltd. operates as a biotechnology company. It engages in the research and development of cell therapies for regenerative biomedicine. The company was founded in August 2003 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 304360 is 16,400 KRW — it has decreased by −4.82% in the past 24 hours. Watch S.BIOMEDICS CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange S.BIOMEDICS CO., LTD. stocks are traded under the ticker 304360.
304360 stock has fallen by −3.24% compared to the previous week, the month change is a −32.51% fall, over the last year S.BIOMEDICS CO., LTD. has showed a 60.78% increase.
304360 reached its all-time high on Jun 25, 2024 with the price of 51,600 KRW, and its all-time low was 6,950 KRW and was reached on Nov 13, 2023. View more price dynamics on 304360 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
304360 stock is 5.71% volatile and has beta coefficient of 0.29. Track S.BIOMEDICS CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is S.BIOMEDICS CO., LTD. there?
Yes, you can track S.BIOMEDICS CO., LTD. financials in yearly and quarterly reports right on TradingView.
304360 net income for the last quarter is −1.61 B KRW, while the quarter before that showed −4.02 B KRW of net income which accounts for 59.90% change. Track more S.BIOMEDICS CO., LTD. financial stats to get the full picture.
No, 304360 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 54.00 employees. See our rating of the largest employees — is S.BIOMEDICS CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. S.BIOMEDICS CO., LTD. EBITDA is −5.37 B KRW, and current EBITDA margin is −46.00%. See more stats in S.BIOMEDICS CO., LTD. financial statements.
Like other stocks, 304360 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade S.BIOMEDICS CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So S.BIOMEDICS CO., LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating S.BIOMEDICS CO., LTD. stock shows the strong sell signal. See more of S.BIOMEDICS CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.